Hormone Solutions Update September 2014
Dear Valued Customer,
So far, it's been an amazing year for Lawley Pharmaceuticals and Hormone Solutions.
In May, we went to Mexico for the 14th World Menopause Congress attended by over 2000 of the world’s leading clinicians. Delegates embraced the news that AndroFeme testosterone cream for women was available for all patients to access.
In June we received full regulatory approval for AndroForte 5 testosterone cream for men based on comparator studies with Androgel. Androgel (also marketed as Testogel) is the world’s most used form of testosterone. This pivotal study is awaiting publication. Below you can see an infographic that provides a cost comparison between AndroForte 5 and Androgel.
In late July, the latest AndroFeme pharmacokinetic study was published in the journal Menopause
. The study went viral across the global medical news feeds. Testosterone use in women still remains one of the most talked about issues in medicine.
There have been some important changes since last year regarding the site of application of AndroFeme testosterone cream for women. The AndroFeme Product and Consumer Info
has been changed accordingly. Please view the article below for details.
Enjoy the news. As always, if you have any questions feel free to contact me directly via email at:
CEO / Medical Director / Pharmacist